{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:33:45Z","timestamp":1772026425608,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-020-00326-w","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T01:02:52Z","timestamp":1581037372000},"page":"337-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["RETRACTED ARTICLE: Downregulation of miR-96 suppresses the profibrogenic functions of cardiac fibroblasts induced by angiotensin II and attenuates atrial fibrosis by upregulating KLF13"],"prefix":"10.1007","volume":"33","author":[{"given":"Lijie","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yili","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2997-1789","authenticated-orcid":false,"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"326_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, et al. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1\u201376.","journal-title":"J Am Coll Cardiol"},{"key":"326_CR2","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.jacc.2015.03.557","volume":"65","author":"BJ Hirsh","year":"2015","unstructured":"Hirsh BJ, Copeland-Halperin RS, Halperin JL. Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences. J Am Coll Cardiol. 2015;65:2239\u201351.","journal-title":"J Am Coll Cardiol"},{"key":"326_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837\u201347.","journal-title":"Circulation"},{"key":"326_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1152\/physrev.00031.2009","volume":"91","author":"U Schotten","year":"2011","unstructured":"Schotten U, Verheule S, Kirchhof P, et al. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011;91:265\u201332525.","journal-title":"Physiol Rev"},{"key":"326_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrd3682","volume":"11","author":"D Dobrev","year":"2012","unstructured":"Dobrev D, Carlsson L, Nattel S. Novel molecular targets for atrial fibrillation therapy. Nat Rev Drug Discovery. 2012;11:275\u201391.","journal-title":"Nat Rev Drug Discovery"},{"key":"326_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jacc.2015.06.1313","volume":"66","author":"MS Dzeshka","year":"2015","unstructured":"Dzeshka MS, Lip GY, Snezhitskiy V, et al. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66:943\u201359.","journal-title":"J Am Coll Cardiol"},{"key":"326_CR7","doi-asserted-by":"publisher","first-page":"19502","DOI":"10.1002\/jcp.28548","volume":"234","author":"Q Dong","year":"2019","unstructured":"Dong Q, Li S, Wang W, et al. FGF23 regulates atrial fibrosis in atrial fibrillation by mediating the STAT3 and SMAD3 pathways. J Cell Physiol. 2019;234:19502\u201310.","journal-title":"J Cell Physiol."},{"key":"326_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13046-014-0113-6","volume":"33","author":"W Zhang","year":"2014","unstructured":"Zhang W, Zhang T, Jin R, et al. MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer. J Exp Clin Cancer Res. 2014;33:113.","journal-title":"J Exp Clin Cancer Res"},{"key":"326_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000493419","volume":"141","author":"W Liu","year":"2018","unstructured":"Liu W, Zheng J, Dong J, et al. Association of miR-197-5p, a circulating biomarker for heart failure, with myocardial fibrosis and adverse cardiovascular events among patients with stage C or D heart failure. Cardiology. 2018;141:212\u201325.","journal-title":"Cardiology"},{"key":"326_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bbrc.2018.09.092","volume":"506","author":"Y Wang","year":"2018","unstructured":"Wang Y, Ma W, Lu S, et al. Androgen receptor regulates cardiac fibrosis in mice with experimental autoimmune myocarditis by increasing microRNA-125b expression. Biochem Biophys Res Commun. 2018;506:130\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"326_CR11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41418-018-0187-3","volume":"26","author":"HH Seo","year":"2019","unstructured":"Seo HH, Lee S, Lee CY, et al. Multipoint targeting of TGF-beta\/Wnt transactivation circuit with microRNA 384-5p for cardiac fibrosis. Cell Death Differ. 2019;26:1107\u201323.","journal-title":"Cell Death Differ"},{"key":"326_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.omtm.2018.10.002","volume":"11","author":"X Luo","year":"2018","unstructured":"Luo X, Zhang D, Xie J, et al. MicroRNA-96 promotes schistosomiasis hepatic fibrosis in mice by suppressing Smad7. Mol Therapy Methods Clin Dev. 2018;11:73\u201382.","journal-title":"Mol Therapy Methods Clin Dev"},{"key":"326_CR13","doi-asserted-by":"publisher","first-page":"L632","DOI":"10.1152\/ajplung.00127.2014","volume":"307","author":"RS Nho","year":"2014","unstructured":"Nho RS, Im J, Ho YY, et al. MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix. Am J Physiol Lung Cell Mol Physiol. 2014;307:L632\u2013L642642.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"326_CR14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12967-015-0672-0","volume":"13","author":"L Fang","year":"2015","unstructured":"Fang L, Ellims AH, Moore XL, et al. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. J Transl Med. 2015;13:314.","journal-title":"J Transl Med"},{"key":"326_CR15","first-page":"39","volume":"2019","author":"PF Li","year":"2019","unstructured":"Li PF, He RH, Shi SB, et al. Modulation of miR-10a-mediated TGF-beta1\/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation. Biosci Rep. 2019;2019:39.","journal-title":"Biosci Rep"},{"key":"326_CR16","first-page":"4642","volume":"22","author":"H Xie","year":"2018","unstructured":"Xie H, Fu JL, Xie C. MiR-138-5p is downregulated in patients with atrial fibrillation and reverses cardiac fibrotic remodeling via repressing CYP11B2. Eur Rev Med Pharmacol Sci. 2018;22:4642\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"326_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13577-018-0208-z","volume":"31","author":"Y Wang","year":"2018","unstructured":"Wang Y, Cai H, Li H, et al. Atrial overexpression of microRNA-27b attenuates angiotensin II-induced atrial fibrosis and fibrillation by targeting ALK5. Hum Cell. 2018;31:251\u201360.","journal-title":"Hum Cell"},{"key":"326_CR18","doi-asserted-by":"publisher","first-page":"E707","DOI":"10.1097\/BRS.0000000000002989","volume":"44","author":"Y Huang","year":"2019","unstructured":"Huang Y, Zhu N, Chen T, et al. Triptolide suppressed the microglia activation to improve spinal cord injury through miR-96\/IKKbeta\/NF-kappaB pathway. Spine. 2019;44:E707\u2013E714714.","journal-title":"Spine"},{"key":"326_CR19","first-page":"773","volume":"17","author":"L Chao","year":"2019","unstructured":"Chao L, Hua-Yu Z, Wen-Dong B, et al. miR-96 promotes collagen deposition in keloids by targeting Smad7. Exp Therapeutic Med. 2019;17:773\u201381.","journal-title":"Exp Therapeutic Med"},{"key":"326_CR20","doi-asserted-by":"publisher","first-page":"7807","DOI":"10.1002\/jcb.27172","volume":"119","author":"C He","year":"2018","unstructured":"He C, Zhang Q, Gu R, et al. miR-96 regulates migration and invasion of bladder cancer through epithelial-mesenchymal transition in response to transforming growth factor-beta1. J Cell Biochem. 2018;119:7807\u201317.","journal-title":"J Cell Biochem"},{"key":"326_CR21","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1016\/j.febslet.2014.11.008","volume":"588","author":"M Yang","year":"2014","unstructured":"Yang M, Pan Y, Zhou Y. miR-96 promotes osteogenic differentiation by suppressing HBEGF-EGFR signaling in osteoblastic cells. FEBS Lett. 2014;588:4761\u20138.","journal-title":"FEBS Lett"},{"key":"326_CR22","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/eurheartj\/ehv375","volume":"37","author":"DH Lau","year":"2016","unstructured":"Lau DH, Schotten U, Mahajan R, et al. Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications. Eur Heart J. 2016;37:1573\u201381.","journal-title":"Eur Heart J"},{"key":"326_CR23","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V. The functions of animal microRNAs. Nature. 2004;431:350\u20135.","journal-title":"Nature"},{"key":"326_CR24","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1152\/physrev.00058.2009","volume":"90","author":"BB McConnell","year":"2010","unstructured":"McConnell BB, Yang VW. Mammalian Kruppel-like factors in health and diseases. Physiol Rev. 2010;90:1337\u2013811.","journal-title":"Physiol Rev"},{"key":"326_CR25","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/nm738","volume":"8","author":"T Shindo","year":"2002","unstructured":"Shindo T, Manabe I, Fukushima Y, et al. Kruppel-like zinc-finger transcription factor KLF5\/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med. 2002;8:856\u201363.","journal-title":"Nat Med"},{"key":"326_CR26","first-page":"175","volume":"16","author":"K Derwinska","year":"2012","unstructured":"Derwinska K, Bartnik M, Wisniowiecka-Kowalnik B, et al. Assessment of the role of copy-number variants in 150 patients with congenital heart defects. Medycyna Wieku Rozwojowego. 2012;16:175\u201382.","journal-title":"Medycyna Wieku Rozwojowego"},{"key":"326_CR27","doi-asserted-by":"publisher","first-page":"19374","DOI":"10.1074\/jbc.M116.725903","volume":"291","author":"D Cruz-Topete","year":"2016","unstructured":"Cruz-Topete D, He B, Xu X, Cidlowski JA. Kruppel-like factor 13 Is a major mediator of glucocorticoid receptor signaling in cardiomyocytes and protects these cells from DNA damage and death. J Biol Chem. 2016;291:19374\u201386.","journal-title":"J Biol Chem"},{"key":"326_CR28","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1038\/sj.emboj.7601379","volume":"25","author":"G Lavallee","year":"2006","unstructured":"Lavallee G, Andelfinger G, Nadeau M, et al. The Kruppel-like transcription factor KLF13 is a novel regulator of heart development. EMBO J. 2006;25:5201\u201313.","journal-title":"EMBO J"}],"updated-by":[{"DOI":"10.1007\/s13577-022-00780-8","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"record-id":"38903"},{"DOI":"10.1007\/s13577-020-00326-w","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000}},{"DOI":"10.1007\/s13577-022-00780-8","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000}}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-020-00326-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-020-00326-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-020-00326-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:43:01Z","timestamp":1772023381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-020-00326-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["326"],"URL":"https:\/\/doi.org\/10.1007\/s13577-020-00326-w","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]},"assertion":[{"value":"30 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13577-022-00780-8","URL":"https:\/\/doi.org\/10.1007\/s13577-022-00780-8","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors confirm that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were performed in accordance with the institutional guidelines from the Care and Use of Laboratory Animals of Shu Guang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine and were approved by the Institutional Animal Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}